AlphaCentric Advisors »

Intra Cellular Therapies shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 20k 69.20
2023-09-30 $1.3M 26k 52.09
2023-06-30 $1.6M 26k 63.32
2023-03-31 $1.4M 26k 54.15
2022-12-31 $397k 7.5k 52.92
2021-09-30 $149k 4.0k 37.25
2021-06-30 $204k 5.0k 40.80
2021-03-31 $238k 7.0k 34.00
2020-12-31 $254k 8.0k 31.75
2020-09-30 $14k 550 25.45